243 results on '"Stokes, Dennis C."'
Search Results
2. Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
3. Pulmonary outcomes in survivors of childhood central nervous system malignancies: A report from the childhood cancer survivor study
4. Recovery of Pulmonary Function after Allogeneic Hematopoietic Cell Transplantation in Children is Associated with Improved Survival
5. Effects of Infection on Function and Development of the Lung
6. Varicella-Zoster Virus Pneumonitis *
7. Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
8. 54 - Pulmonary Disease in the Immunosuppressed Pediatric Patient
9. Pulmonary Disease in the Pediatric Patient With Acquired Immunodeficiency States
10. Contributors
11. Supplementary Table 1 from Cigarette Smoking and Pulmonary Function in Adult Survivors of Childhood Cancer Exposed to Pulmonary-Toxic Therapy: Results from the St. Jude Lifetime Cohort Study
12. Supplementary Figure 1 from Cigarette Smoking and Pulmonary Function in Adult Survivors of Childhood Cancer Exposed to Pulmonary-Toxic Therapy: Results from the St. Jude Lifetime Cohort Study
13. Supplementary Data from Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors
14. Supplementary Table 2 from Cigarette Smoking and Pulmonary Function in Adult Survivors of Childhood Cancer Exposed to Pulmonary-Toxic Therapy: Results from the St. Jude Lifetime Cohort Study
15. Supplementary Figure Legends from Cigarette Smoking and Pulmonary Function in Adult Survivors of Childhood Cancer Exposed to Pulmonary-Toxic Therapy: Results from the St. Jude Lifetime Cohort Study
16. Long-Term Pulmonary Function after Metastasectomy for Childhood Osteosarcoma: A Report from the St Jude Lifetime Cohort Study
17. Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor: Case Series
18. Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors
19. Pulmonary Outcomes in Survivors of Childhood Cancer: A Systematic Review
20. Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis
21. Casting a Shadow. A 13-Year-Old Girl with Acute Chest Syndrome and Respiratory Failure
22. Pre-Hematopoietic Stem Cell Transplant Lung Function and Pulmonary Complications in Children
23. F1099L-CFTR (c.3297C>
24. Pulmonary Disease in the Pediatric Patient with Acquired Immunodeficiency States
25. Contributors
26. Pulmonary disease after treatment for wilms tumor: A report from the national wilms tumor long-term follow-up study
27. The (Pediatric Pulmonary) World Is Flat. The Spread of Internet-based Pediatric Pulmonary Case Conferences
28. A Young Hispanic with c.1646G>A Mutation Exhibits Severe Cystic Fibrosis Lung Disease: Is Ivacaftor an Option for Therapy?
29. Pulmonary function after whole lung irradiation in pediatric patients with solid malignancies
30. F1099L-CFTR (c.3297C>G) has Impaired Channel Function and Associates with Mild Disease Phenotypes in Two Pediatric Patients
31. Contributors
32. Respiratory Infections in Immunocompromised Hosts
33. Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation
34. Pulmonary Infections in the Immunocompromised Pediatric Host
35. Contributors
36. Clinical and Molecular Characterization of S1118F-CFTR
37. 64 - Pulmonary Disease in the Pediatric Patient With Acquired Immunodeficiency States
38. Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine
39. Polymyxin B Prevents Lipopolysaccharide-Induced Release of Tumor Necrosis Factor-α from Alveolar Macrophages
40. Polymyxin B Moderates Acidosis and Hypotension in Established, Experimental Gram-Negative Septicemia
41. Binding of Polymyxin B to Rat Alveolar Macrophages
42. Reversal of Dopamine-Refractory Septic Shock by Diethyldithiocarbamate, an Inhibitor of Endothelium-Derived Relaxing Factor
43. Respiratory Care Considerations in the Childhood Cancer Patient
44. Colaboradores
45. 64 - Enfermedades pulmonares en los pacientes pediátricos con un estado de inmunodeficiencia adquirida
46. The Hidden Value of Variation in Practice
47. Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE)
48. Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation
49. 62 - Pulmonary Disease in the Pediatric Patient with Acquired Immunodeficiency States
50. c.3623G > A mutation encodes a CFTR protein with impaired channel function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.